Publikationen

zurück zu Unsere Erfolge

Viskochil RH, Lin T, Gigic B, Himbert C, Bandera VM, Skender S, Holowatyj AN, Schrotz-King P, Steindorf K, Strehli I, Mutch MG, Chao D, Toriola AT, Shibata D, Siegel EM, Li CI, Hardikar S, Peoples AR, Figueiredo JC, Schneider M, Ulrich CM, and Ose J (2025). Sedentary behavior and physical activity one year after colorectal cancer diagnosis: results from the ColoCare Study. J Cancer Surviv.

Holthuijsen DDB, Rijnhart JJM, Bours MJL, van Roekel EH, Ueland PM, Breukink SO, Janssen-Heijnen MLG, Konsten JL, Keulen ETP, McCann A, Brezina S, Gigic B, Ulrich CM, Weijenberg MP, and Eussen S (2025). Longitudinal associations of dietary intake with fatigue in colorectal cancer survivors up to 1 year post-treatment, and the potential mediating role of the kynurenine pathway. Brain Behav Immun.

Byrd DA, Damerell V, Gomez Morales MF, Hogue SR, Lin T, Ose J, Himbert C, Ilozumba MN, Kahlert C, Shibata D, Toriola AT, Li CI, Figueiredo J, Stephens WZ, Warby CA, Hardikar S, Siegel EM, Round J, Ulrich CM, and Gigic B (2025). The gut microbiome is associated with disease-free survival in stage I-III colorectal cancer patients. Int J Cancer.

Brandl A, and van Sandick JW (2024). Treatment of gastric cancer peritoneal metastases: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 111.

Rau B, Lang H, Koenigsrainer A, Gockel I, Rau HG, Seeliger H, Lerchenmueller C, Reim D, Wahba R, Angele M, Heeg S, Keck T, Weimann A, Topp S, Piso P, Brandl A, Schuele S, Jo P, Pratschke J, Wegel S, Rehders A, Moosmann N, Gaedcke J, Heinemann V, Trips E, Loeffler M, Schlag PM, and Thuss-Patience P (2024). Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial. J Clin Oncol 42, 146-156.

Zhou Z, Kleis L, Depetris-Chauvin A, Jaskulski S, Damerell V, Michels KB, Gigic B, Nothlings U, and Panagiotou G (2024). Beneficial microbiome and diet interplay in early-onset colorectal cancer. EMBO Mol Med.

Rompen IF, Billeter AT, Crnovrsanin N, Sisic L, Neuschutz KJ, Musa J, Bolli M, Fourie L, Kraljevic M, Al-Saeedi M, Nienhuser H, and Muller-Stich BP (2024). Definition and Predictors of Early Recurrence in Neoadjuvantly Treated Esophageal and Gastroesophageal Adenocarcinoma: a Dual-Center Retrospective Cohort Study. Ann Surg Oncol.

Valenti G, Laise P, Takahashi R, Wu F, Ruan T, Vasciaveo A, Jiang Z, Sunagawa M, Middelhoff M, Nienhuser H, Fu N, Malagola E, Hayakawa Y, Iuga AC, Califano A, and Wang TC (2024). Regulatory network analysis of Dclk1 gene expression reveals a tuft cell-ILC2 axis that inhibits pancreatic tumor progression. bioRxiv.

Knipper K, Lyu SI, Jung JO, Alich N, Popp FC, Schroder W, Fuchs HF, Bruns CJ, Quaas A, Nienhueser H, and Schmidt T (2024). Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma. Sci Rep 14, 20589.

Wirsik NM, Kooij CD, Dempster N, Crnovrsanin N, Donlon NE, Uzun E, Bhanot K, Nienhuser H, Polette D, Kewani K, Grimminger P, Reim D, Seyfried F, Fuchs HF, Gisbertz SS, Germer CT, Ruurda JP, Klevebro F, Schroder W, Nilsson M, Reynolds JV, Van Berge Henegouwen MI, Markar S, Van Hillegersberg R, Schmidt T, and Bruns CJ (2024). Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort Analysis. Ann Surg 280, 799-807.

Schneider MA, Kim J, Berlth F, Sugita Y, Grimminger PP, Wijnhoven BPL, Overtoom H, Gockel I, Thieme R, Griffiths EA, Butterworth W, Nienhuser H, Muller B, Crnovrsanin N, Gero D, Nickel F, Gisbertz S, van Berge Henegouwen MI, Pucher PH, Khan K, Chaudry A, Patel PH, Pera M, Dal Cero M, Garcia C, Martinez Salinas G, Kassab P, Prado Castro OA, Norero E, Wisniowski P, Putnam LR, Lombardi PM, Ferrari G, Gudaityte R, Maleckas A, Prodehl L, Castaldi A, Prudhomme M, Lee HJ, Sano T, Baiocchi GL, De Manzoni G, Giacopuzzi S, Bencivenga M, Rosati R, Puccetti F, D'Ugo D, Nunobe S, Yang HK, Gutschow CA, and consortium G (2024). Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases. Ann Surg 280, 788-798.

Studier-Fischer A, Bressan M, Qasim AB, Ozdemir B, Sellner J, Seidlitz S, Haney CM, Egen L, Michel M, Dietrich M, Salg GA, Billmann F, Nienhuser H, Hackert T, Muller BP, Maier-Hein L, Nickel F, and Kowalewski KF (2024). Spectral characterization of intraoperative renal perfusion using hyperspectral imaging and artificial intelligence. Sci Rep 14, 17262.

Studier-Fischer A, Ozdemir B, Kowalewski KF, Haney CM, Egen L, Michel MS, Mieth M, Czigany Z, Salg GA, Nienhuser H, and Billmann F (2024). Controlled Reversible Visceral Arterial Ischemia, Venous Congestion and Combined Malperfusion via Midline Laparotomy in Rats. J Vis Exp.

Studier-Fischer A, Ozdemir B, Rees M, Ayala L, Seidlitz S, Sellner J, Kowalewski KF, Haney CM, Odenthal J, Knodler S, Dietrich M, Gruneberg D, Brenner T, Schmidt K, Schmitt FCF, Weigand MA, Salg GA, Dupree A, Nienhuser H, Mehrabi A, Hackert T, Muller BP, Maier-Hein L, and Nickel F (2024). Crystalloid volume versus catecholamines for management of hemorrhagic shock during esophagectomy - assessment of microcirculatory tissue oxygenation of the gastric conduit in a porcine model using hyperspectral imaging - an experimental study. Int J Surg 110, 6558-6572.

Rompen IF, Schutte I, Crnovrsanin N, Schiefer S, Billeter AT, Haag GM, Longerich T, Czigany Z, Schmidt T, Billmann F, Sisic L, and Nienhuser H (2024). Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric Adenocarcinoma. Ann Surg Oncol 31, 6900-6908.

Malagola E, Vasciaveo A, Ochiai Y, Kim W, Zheng B, Zanella L, Wang ALE, Middelhoff M, Nienhuser H, Deng L, Wu F, Waterbury QT, Belin B, LaBella J, Zamechek LB, Wong MH, Li L, Guha C, Cheng CW, Yan KS, Califano A, and Wang TC (2024). Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury. Cell 187, 3056-3071 e3017.

Schiefer S, Crnovrsanin N, Kalkum E, Vey JA, Nienhuser H, Rompen IF, Haag GM, Muller-Stich B, Billmann F, Schmidt T, Probst P, Klotz R, and Sisic L (2024). Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? A systematic review and meta-analysis. Front Surg 11, 1382039.

Wirsik NM, Appel PC, Braun A, Strowitzki MJ, Schleussner N, Nienhuser H, Schneider M, and Schmidt T (2024). Inhibition of the Renin-Angiotensin System Improves Response to Neoadjuvant Therapy in Patients With Liver Metastasis of Colorectal Cancers. J Surg Res 298, 176-184.

Wirsik NM, Chen M, He L, Yasar U, Gaukel J, Quaas A, Nienhuser H, Leugner E, Yuan S, Schleussner N, Jung JO, Plucker JS, Schneider M, and Schmidt T (2024). Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma. Cancer Med 13, e6866.

Schneider MA, Kim J, Berlth F, Sugita Y, Grimminger PP, Sano T, Rosati R, Baiocchi GL, Bencivenga M, De Manzoni G, Nunobe S, Yang HK, Gutschow CA, GastroBenchmark C, and Consortium G (2024). Defining benchmarks for total and distal gastrectomy: global multicentre analysis. Br J Surg 111.

Nienhuser H, and Schmidt T (2024). [Evidence for Minimal Invasive Oesophageal Resection]. Zentralbl Chir 149, 163-168.

Wirsik NM, Stengel S, Jung JO, Sisic L, Crnovrsanin N, Nienhuser H, Schleussner N, Hamm A, Buchler MW, and Schmidt T (2024). Inhibition of the renin-angiotensin system in patients with upper gastrointestinal adenocarcinoma. Br J Surg 111.

Ilozumba MN, Lin T, Hardikar S, Byrd DA, Round JL, Stephens WZ, Holowatyj AN, Warby CA, Damerell V, Li CI, Figueiredo JC, Toriola AT, Shibata D, Fillmore GC, Pickron B, Siegel EM, Kahlert C, Florou V, Gigic B, Ose J, and Ulrich CM (2024). Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study. Cancer Med 13, e70431.

Lorona NC, Himbert C, Ose J, Cohen SA, Strehli I, Ulrich CM, Cobos S, Jean-Baptiste E, Bloomer AM, Figueiredo JC, Gigic B, Hardikar S, Karchi M, Mutch M, Peoples AR, Schneider M, Shibata D, Siegel EM, Toriola AT, Wood EH, and Li CI (2024). Alcohol consumption and smoking history at time of diagnosis, and risk of colorectal cancer recurrence and mortality: Results from the ColoCare Study. Cancer Epidemiol Biomarkers Prev.

Damerell V, Klaassen-Dekker N, Brezina S, Ose J, Ulvik A, van Roekel EH, Holowatyj AN, Baierl A, Bohm J, Bours MJL, Brenner H, de Wilt JHW, Grady WM, Habermann N, Hoffmeister M, Keski-Rahkonen P, Lin T, Schirmacher P, Schrotz-King P, Ulrich AB, van Duijnhoven FJB, Warby CA, Shibata D, Toriola AT, Figueiredo JC, Siegel EM, Li CI, Gsur A, Kampman E, Schneider M, Ueland PM, Weijenberg MP, Ulrich CM, Kok DE, Gigic B, and Consortium F (2024). Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer. Int J Cancer.

Holthuijsen DDB, van Roekel EH, Bours MJL, Ueland PM, Breukink SO, Janssen-Heijnen MLG, Keulen ETP, Brezina S, Gigic B, Peoples AR, Ulrich CM, Ulvik A, Weijenberg MP, and Eussen S (2024). Longitudinal associations of plasma kynurenines and ratios with fatigue and quality of life in colorectal cancer survivors up to 12 months post-treatment. Int J Cancer.

Oswald LB, Bloomer A, Li X, Jean-Baptiste E, Trujillo G, Felder S, Small BJ, Ose J, Hardikar S, Strehli I, Huang LC, Mooney K, Mutch MG, Chao D, Cohen SA, Karchi M, Wood EH, Damerell V, Lorona NC, Gong J, Toriola AT, Li CI, Shibata D, Schneider M, Gigic B, Figueiredo JC, Jim HSL, Ulrich CM, and Siegel EM (2024). Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study. Support Care Cancer 32, 298.

Assmann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK, Jr., Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, and Peoples AR (2024). Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. J Behav Med 47, 405-421.

Crowder SL, Li X, Himbert C, Viskochil R, Hoogland AI, Gudenkauf LM, Oswald LB, Gonzalez BD, Small BJ, Ulrich CM, Ose J, Peoples AR, Li CI, Shibata D, Toriola AT, Gigic B, Playdon MC, Hardikar S, Bower J, Siegel EM, Figueiredo JC, and Jim HSL (2024). Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study. Ann Behav Med 58(3):156-166.

Holthuijsen DDB, van Roekel EH, Bours MJL, Ueland PM, Breukink SO, Janssen-Heijnen MLG, Keulen ETP, Gigic B, Gsur A, Meyer K, Ose J, Ulvik A, Weijenberg MP, and Eussen S (2024). Longitudinal associations of plasma kynurenines and ratios with anxiety and depression scores in colorectal cancer survivors up to 12 months post-treatment. Psychoneuroendocrinology 163, 106981

Jiang D, Mantas A, Studier-Fischer A, Fuchs J, Uluk D, Loos M, Mieth M, Zeier M, Husen P, Golriz M, Kahlert C, Ryschich E, Mehrabi A, Pratschke J, Michalski CW, and Czigany Z (2024). Clinical Research in Renal Transplantation: A Bibliometric Perspective on a Half-century of Innovation and Progress. Transplantation.

Studier-Fischer A, Schwab FM, Rees M, Seidlitz S, Sellner J, Ozdemir B, Ayala L, Odenthal J, Knoedler S, Kowalewski KF, Haney CM, Dietrich M, Salg GA, Kenngott HG, Muller-Stich BP, Maier-Hein L, and Nickel F (2023). ICG-augmented hyperspectral imaging for visualization of intestinal perfusion compared to conventional ICG fluorescence imaging: an experimental study. Int J Surg 109, 3883-3895.

Jung JO, Crnovrsanin N, Wirsik NM, Nienhuser H, Peters L, Popp F, Schulze A, Wagner M, Muller-Stich BP, Buchler MW, and Schmidt T (2023). Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer. J Cancer Res Clin Oncol 149, 1691-1702.

Sisic L, Crnovrsanin N, Nienhueser H, Jung JO, Schiefer S, Haag GM, Bruckner T, Schneider M, Muller-Stich BP, Buchler MW, and Schmidt T (2023). Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective. Langenbecks Arch Surg 408, 81.

Hess T, Maj C, Gehlen J, Borisov O, Haas SL, Gockel I, Vieth M, Piessen G, Alakus H, Vashist Y, Pereira C, Knapp M, Schuller V, Quaas A, Grabsch HI, Trautmann J, Malecka-Wojciesko E, Mokrowiecka A, Speller J, Mayr A, Schroder J, Hillmer AM, Heider D, Lordick F, Perez-Aisa A, Campo R, Espinel J, Geijo F, Thomson C, Bujanda L, Sopena F, Lanas A, Pellise M, Pauligk C, Goetze TO, Zelck C, Reingruber J, Hassanin E, Elbe P, Alsabeah S, Lindblad M, Nilsson M, Kreuser N, Thieme R, Tavano F, Pastorino R, Arzani D, Persiani R, Jung JO, Nienhuser H, Ott K, Schumann RR, Kumpf O, Burock S, Arndt V, Jakubowska A, Lawniczak M, Moreno V, Martin V, Kogevinas M, Pollan M, Dabrowska J, Salas A, Cussenot O, Boland-Auge A, Daian D, Deleuze JF, Salvi E, Teder-Laving M, Tomasello G, Ratti M, Senti C, De Re V, Steffan A, Holscher AH, Messerle K, Bruns CJ, Sivins A, Bogdanova I, Skieceviciene J, Arstikyte J, Moehler M, Lang H, Grimminger PP, Kruschewski M, Vassos N, Schildberg C, Lingohr P, Ridwelski K, Lippert H, Fricker N, Krawitz P, Hoffmann P, Nothen MM, Veits L, Izbicki JR, Mostowska A, Martinon-Torres F, Cusi D, Adolfsson R, Cancel-Tassin G, Hoblinger A, Rodermann E, Ludwig M, Keller G, Metspalu A, Brenner H, Heller J, Neef M, Schepke M, Dumoulin FL, Hamann L, Cannizzaro R, Ghidini M, Plassmann D, Geppert M, Malfertheiner P, Gehlen O, Skoczylas T, Majewski M, Lubinski J, Palmieri O, Boccia S, Latiano A, Aragones N, Schmidt T, Dinis-Ribeiro M, Medeiros R, Al-Batran SE, Leja M, Kupcinskas J, Garcia-Gonzalez MA, Venerito M, and Schumacher J (2023). Dissecting the genetic heterogeneity of gastric cancer. EBioMedicine 92, 104616.

Rompen IF, Nienhuser H, Crnovrsanin N, Musa J, Haag GM, Longerich T, Fiedler T, Muller-Stich BP, Sisic L, and Billeter AT (2023). Clinical Characteristics and Oncological Outcomes of Surgically Treated Early-Onset Gastric Adenocarcinoma - a Retrospective Cohort Study. J Cancer 14, 1470-1478.

Wirsik NM, Schmidt T, Nienhuser H, Donlon NE, de Jongh C, Uzun E, Fuchs HF, Brunner S, Alakus H, Holscher AH, Grimminger P, Schneider M, Reynolds JV, van Hillegersberg R, and Bruns CJ (2023). Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis. Ann Surg 278, 683-691.

Stelmach R, Apostolidis L, Kahle S, Sisic L, Nienhuser H, Weber TF, Jager D, and Haag GM (2023). Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up. J Cancer Res Clin Oncol 149, 14785-14796.

Rompen IF, Crnovrsanin N, Nienhuser H, Neuschutz K, Fourie L, Sisic L, Muller-Stich BP, and Billeter AT (2023). Age dependent benefit of neoadjuvant treatment in adenocarcinoma of the esophagus and gastroesophageal junction - a multicenter retrospective observational study of young versus old patients. Int J Surg 109, 3804-3814.

Li X, Hoogland AI, Small BJ, Crowder SL, Gonzalez BD, Oswald LB, Sleight AG, Nguyen N, Lorona NC, Damerell V, Komrokji KR, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Siegel EM, Bower JE, Schneider M, Gigic B, Figueiredo JC, and Jim HSL (2023). Trajectories and risk factors of fatigue following colorectal cancer diagnosis. Colorectal Dis.

Himbert C, Ose J, Gigic B, Viskochil R, Santuci K, Lin T, Ashworth A, Cohan JN, Scaife CL, Jedrzkiewicz J, Damerell V, Atkins KM, Gong J, Mutch MG, Bernadt C, Felder S, Sanchez J, Cohen SA, Krane MK, Hinkle N, Wood E, Peoples AR, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Shibata D, Boucher K, Round JL, Ulrich AB, Schneider M, Huang LC, Hardikar S, and Ulrich CM (2023). Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes. BMC Cancer 23, 300.

Yu M, Carter KT, Baker KK, Redman MW, Wang T, Vickers K, Li CI, Cohen SA, Krane M, Ose J, Gigic B, Figueiredo JC, Toriola AT, Siegel EM, Shibata D, Schneider M, Ulrich CM, Dzubinski LA, Schoen RE, and Grady WM (2023). Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing recurrent adenomas. Cancer Epidemiol Biomarkers Prev.

Ose J, Gigic B, Brezina S, Lin T, Peoples AR, Schobert PP, Baierl A, van Roekel E, Robinot N, Gicquiau A, Achaintre D, Scalbert A, van Duijnhoven FJB, Holowatyj AN, Gumpenberger T, Schrotz-King P, Ulrich AB, Ulvik A, Ueland PM, Weijenberg MP, Habermann N, Keski-Rahkonen P, Gsur A, Kok DE, and Ulrich CM (2023). Higher Plasma Creatinine Is Associated with an Increased Risk of Death in Patients with Non-Metastatic Rectal but Not Colon Cancer: Results from an International Cohort Consortium. Cancers (Basel) 15.

Zhang C, Al-Shaheri FN, Alhamdani MSS, Bauer AS, Hoheisel JD, Schenk M, Hinz U, Goedecke P, Al-Halabi K, Buchler MW, Giese NA, Hackert T, and Roth S (2023). Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN). Clin Cancer Res 29, 1535-1545.

Yousuf S, Qiu M, Voith von Voithenberg L, Hulkkonen J, Macinkovic I, Schulz AR, Hartmann D, Mueller F, Mijatovic M, Ibberson D, AlHalabi KT, Hetzer J, Anders S, Brune B, Mei HE, Imbusch CD, Brors B, Heikenwalder M, Gaida MM, Buchler MW, Weigert A, Hackert T, and Roth S (2023). Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer. Gastroenterology.

Studier-Fischer A, Seidlitz S, Sellner J, Bressan M, Ozdemir B, Ayala L, Odenthal J, Knoedler S, Kowalewski KF, Haney CM, Salg G, Dietrich M, Kenngott H, Gockel I, Hackert T, Muller-Stich BP, Maier-Hein L, and Nickel F (2023). HeiPorSPECTRAL - the Heidelberg Porcine HyperSPECTRAL Imaging Dataset of 20 Physiological Organs. Sci Data 10, 414.

Lindley CL, Gigic B, Peoples AR, Han CJ, Lin T, Himbert C, Warby CA, Boehm J, Hardikar S, Ashworth A, Schneider M, Ulrich A, Schrotz-King P, Figueiredo JC, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich CM, Syrjala KL, and Ose J (2023). Pre-surgery inflammatory and angiogenesis biomarkers as predictors of 12-month cancer-related distress: Results from the ColoCare Study. Cancer Epidemiol Biomarkers Prev.

Campa D, Gentiluomo M, Stein A, Aoki MN, Oliverius M, Vodickova L, Jamroziak K, Theodoropoulos G, Pasquali C, Greenhalf W, Arcidiacono PG, Uzunoglu F, Pezzilli R, Luchini C, Puzzono M, Loos M, Giaccherini M, Katzke V, Mambrini A, Kiudeliene E, Federico KE, Johansen J, Hussein T, Mohelnikova-Duchonova B, van Eijck CHJ, Brenner H, Farinella R, Perez JS, Lovecek M, Buchler MW, Hlavac V, Izbicki JR, Hackert T, Chammas R, Zerbi A, Lawlor R, Felici A, Gotz M, Capurso G, Ginocchi L, Gazouli M, Kupcinskas J, Cavestro GM, Vodicka P, Moz S, Neoptolemos JP, Kunovsky L, Bojesen SE, Carrara S, Gioffreda D, Morkunas E, Abian O, Bunduc S, Basso D, Boggi U, Wlodarczyk B, Szentesi A, Vanella G, Chen I, Bijlsma MF, Kiudelis V, Landi S, Schottker B, Corradi C, Giese N, Kaaks R, Peduzzi G, Hegyi P, Morelli L, Furbetta N, Soucek P, Latiano A, Talar-Wojnarowska R, Lindgaard SC, Dijk F, Milanetto AC, Tavano F, Cervena K, Eross B, Testoni SG, Verhagen-Oldenampsen JHE, Malecka-Wojciesko E, Costello E, Salvia R, Maiello E, Ermini S, Sperti C, Holleczek B, Perri F, Skieceviciene J, Archibugi L, Lucchesi M, Rizzato C, and Canzian F (2023). The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Crit Rev Oncol Hematol 186, 104020.

Berghuijs K, Kaddas HK, Trujillo G, Rouhani G, Chevrier A, Ose J, Shibata D, Toriola AT, Figueiredo JC, Peoples AR, Li CI, Hardikar S, Siegel EM, Gigic B, Schneider M, Ulrich CM, and Kirchhoff AC (2023). Age-related differences in employment, insurance, and financial hardship among colorectal cancer patients: a report from the ColoCare Study. J Cancer Surviv.

Ahmed A, Kohler S, Klotz R, Giese N, Hackert T, Springfeld C, Jager D, and Halama N (2023). Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Cancers (Basel) 15.

Reichelt S, Pratschke J, Engelmann C, Neumann UP, Lurje G, and Czigany Z (2022). Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities. Am J Transplant 22, 1943-1957.

Nickel F, Studier-Fischer A, Hausmann D, Klotz R, Vogel-Adigozalov SL, Tenckhoff S, Klose C, Feisst M, Zimmermann S, Babic B, Berlt F, Bruns C, Gockel I, Graf S, Grimminger P, Gutschow CA, Hoeppner J, Ludwig K, Mirow L, Monig S, Reim D, Seyfried F, Stange D, Billeter A, Nienhuser H, Probst P, Schmidt T, and Muller-Stich BP (2022). Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765). BMJ Open 12, e064286.

Zhang C, Al-Shaheri FN, Alhamdani MSS, Bauer AS, Hoheisel JD, Schenk M, Hinz U, Goedecke P, Al-Halabi K, Buchler MW, Giese NA, Hackert T, and Roth S (2022). Blood-based diagnosis and risk stratification of patients with pancreatic intraductal papillary mucinous neoplasm (IPMN). Clin Cancer Res.

Walle T, Kraske JA, Liao B, Lenoir B, Timke C, von Bohlen Und Halbach E, Tran F, Griebel P, Albrecht D, Ahmed A, Suarez-Carmona M, Jimenez-Sanchez A, Beikert T, Tietz-Dahlfuss A, Menevse AN, Schmidt G, Brom M, Pahl JHW, Antonopoulos W, Miller M, Perez RL, Bestvater F, Giese NA, Beckhove P, Rosenstiel P, Jager D, Strobel O, Pe'er D, Halama N, Debus J, Cerwenka A, and Huber PE (2022). Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8. Sci Adv 8, eabh4050.

Strowitzki MJ, Nelson R, Garcia MP, Tuffs C, Bleul MB, Fitzsimons S, Navas J, Uzieliene I, Ritter AS, Phelan D, Kierans SJ, Blanco A, Bernotiene E, Belton O, Schneider M, Cummins EP, and Taylor CT (2022). Carbon Dioxide Sensing by Immune Cells Occurs through Carbonic Anhydrase 2-Dependent Changes in Intracellular pH. J Immunol 208, 2363-2375.

Stewart KL, Gigic B, Himbert C, Warby CA, Ose J, Lin T, Schrotz-King P, Boehm J, Jordan KC, Metos J, Schneider M, Figueiredo JC, Li CI, Shibata D, Siegel E, Toriola AT, Hardikar S, and Ulrich CM (2022). Association of Sugar Intake with Inflammation- and Angiogenesis-Related Biomarkers in Newly Diagnosed Colorectal Cancer Patients. Nutr Cancer 74, 1636-1643.

Schuth S, Le Blanc S, Krieger TG, Jabs J, Schenk M, Giese NA, Buchler MW, Eils R, Conrad C, and Strobel O (2022). Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J Exp Clin Cancer Res 41, 312.

Salg GA, Poisel E, Neulinger-Munoz M, Gerhardus J, Cebulla D, Bludszuweit-Philipp C, Vieira V, Nickel F, Herr I, Blaeser A, Giese NA, Hackert T, and Kenngott HG (2022). Toward 3D-bioprinting of an endocrine pancreas: A building-block concept for bioartificial insulin-secreting tissue. J Tissue Eng 13, 20417314221091033.

Ose J, Gigic B, Hardikar S, Lin T, Himbert C, Warby CA, Peoples AR, Lindley CL, Boehm J, Schrotz-King P, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Ulrich A, Schneider M, Shibata D, and Ulrich CM (2022). Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study. Cancer Epidemiol Biomarkers Prev 31, 1650-1660.

Leinenkugel G, Kong B, Raulefs S, Miller K, Roth S, Jiang H, Istvanffy R, Heikenwalder H, Maeritz N, Regel I, Abiatari I, Kleeff J, Michalski CW, and Rieder S (2022). Sca-1 is a marker for cell plasticity in murine pancreatic epithelial cells and induced by IFN-beta in vitro. Pancreatology 22, 294-303.

Himbert C, Warby CA, Gigic B, Ose J, Lin T, Viskochil R, Peoples AR, Ashworth A, Schrotz-King P, Scaife CL, Cohan JN, Jedrzkiewicz J, Schirmacher P, Grady WM, Cohen SA, Krane M, Figueiredo JC, Toriola AT, Siegel EM, Shibata D, Round JL, Huang LC, Li CI, Schneider M, Ulrich A, Hardikar S, and Ulrich CM (2022). Associations of individual and combined physical activity and body mass index groups with pro-inflammatory biomarkers among colorectal cancer patients. Cancer Epidemiol Biomarkers Prev.

Himbert C, Stephens WZ, Gigic B, Hardikar S, Holowatyj AN, Lin T, Ose J, Swanson E, Ashworth A, Warby CA, Peoples AR, Nix D, Jedrzkiewicz J, Bronner M, Pickron B, Scaife C, Cohan JN, Schrotz-King P, Habermann N, Boehm J, Hullar M, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Ulrich AB, Shibata D, Boucher K, Huang LC, Schneider M, Round JL, and Ulrich CM (2022). Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients. Am J Cancer Res 12, 4789-4801.

Heger U, Martens A, Schillings L, Walter B, Hartmann D, Hinz U, Pausch T, Giese N, Michalski CW, and Hackert T (2022). Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma. Cancers (Basel) 14.

He L, Boulant S, Stanifer M, Guo C, Niessen A, Chen M, Felix K, Bergmann F, Strobel O, and Schimmack S (2022). The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms. Cancer Sci 113, 1575-1586.

Harnoss JM, Cai J, Hinterkopf S, Radhakrishnan P, Schmitt A, Dupovac M, Nees LK, Strowitzki MJ, Taylor CT, and Schneider M (2022). Prolyl Hydroxylase Inhibition Mitigates Allograft Injury During Liver Transplantation. Transplantation 106, e430-e440.

Gigic B, van Roekel E, Holowatyj AN, Brezina S, Geijsen A, Ulvik A, Ose J, Koole JL, Damerell V, Kiblawi R, Gumpenberger T, Lin T, Kvalheim G, Koelsch T, Kok DE, van Duijnhoven FJ, Bours MJ, Baierl A, Li CI, Grady W, Vickers K, Habermann N, Schneider M, Kampman E, Ueland PM, Ulrich A, Weijenberg M, Gsur A, Ulrich C, and Consortium F (2022). Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival - the FOCUS Consortium. BMJ Open 12, e062930.

Gentiluomo M, Capurso G, Morelli L, Ermini S, Pasquali C, Latiano A, Tavano F, Greenhalf W, Milanetto AC, Landi S, Roth S, Malecka-Wojciesko E, Costello E, Jamroziak K, Perri F, Boggi U, Basso D, Farinati F, Kaaks R, Vanella G, Gais Zurcher AJ, Archibugi L, Lawlor RT, Canzian F, and Campa D (2022). Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset. Neuroendocrinology 112, 1168-1176.

Felix K, Honda K, Nagashima K, Kashiro A, Takeuchi K, Kobayashi T, Hinterkopf S, Gaida MM, Dang H, Brindl N, Kaiser J, Buchler MW, and Strobel O (2022). Noninvasive risk stratification of intraductal papillary mucinous neoplasia with malignant potential by serum apolipoprotein-A2-isoforms. Int J Cancer 150, 881-894.

Brindl N, Boekhoff H, Bauer AS, Gaida MM, Dang HT, Kaiser J, Hoheisel JD, and Felix K (2022). Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy. Cancers (Basel) 14.

Biller ML, Tuffs C, Bleul M, Tran DT, Dupovac M, Keppler U, Harnoss JM, Probst P, Schneider M, and Strowitzki MJ (2022). Effect of Metformin on HIF-1alpha Signaling and Postoperative Adhesion Formation. J Am Coll Surg 234, 1167-1180.

Ahmed A, Kohler S, Klotz R, Giese N, Hackert T, Springfeld C, Zornig I, Jager D, and Halama N (2022). Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma. Oncoimmunology 11, 2027148.31.

Ahmed A, Klotz R, Kohler S, Giese N, Hackert T, Springfeld C, Jager D, and Halama N (2022). Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma. Front Immunol 13, 947407.